Top Markets
#1 Pleasing Gold Pleasing Gold +1,496.37%
#2 PulseChain PulseChain +58.12%
#3 Ontology Gas Ontology Gas +39.10%
#4 Merlin's Seal BTC Merlin's Seal BTC +33.44%
#5 BOOK OF MEME BOOK OF MEME +30.66%
#6 Pump.fun Pump.fun +25.16%
#7 Unit Pump Unit Pump +25.16%
#8 Neiro Neiro +23.96%
#9 ConstitutionDAO ConstitutionDAO +23.34%
#10 Collect on Fanable Collect on Fanable +22.35%
Coin of the day
Pleasing Gold Pleasing Gold
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Surface Oncology, Inc. Surface Oncology, Inc.

Surface Oncology, Inc.

SURF
Classificação em ações #26176
Surface Oncology, Inc. is a clinical-stage biotechnology firm focused on... Surface Oncology, Inc. is a clinical-stage biotechnology firm focused on discovering and developing innovative immuno-oncology treatments for cancer patients in the United States. Its pipeline features a range of antibody-based therapeutics, including NZV930, a fully human IgG4 monoclonal antibody designed to modulate extracellular adenosine production, and SRF617, another human IgG4 monoclonal antibody that aims to block CD39's enzymatic activity, thereby influencing adenosine levels and ATP degradation. Other key candidates include SRF388, which targets interleukin 27; GSK4381562, an antibody aimed at CD112R, an inhibitory protein found on natural killer and T cells; and SRF114, which targets the chemokine receptor CCR8. The company also maintains strategic partnerships, holding a licensing agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited for the development, manufacturing, and commercialization of SRF813-targeting antibodies. Furthermore, it has a separate licensing deal with Vaccinex, Inc. concerning the development, production, and commercialization of antibodies targeting SRF114. Established in 2014, Surface Oncology, Inc. operates from its headquarters in Cambridge, Massachusetts.
Preço da ação
$1.07
Última sincronização: 2023-09-12
Valor de mercado
$42.80M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Surface Oncology, Inc. (SURF)

Categoria

Healthcare
Histórico de dividendos de Surface Oncology, Inc. (SURF)
Surface Oncology, Inc. (símbolo da ação: SURF) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Surface Oncology, Inc. (SURF) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US